Sign In | Register Now
TODAY'S NEWSPAPER
Subscribe | PostPoints
Sign Up: Free Daily Tech E-letter  
Technology Home
Washtech
   -Companies
Tech Policy
Government IT
Markets
Columnists
Personal Tech
Special Reports
Jobs

Advertisement
Company Postings
Get Quotes
Press Releases
Tech Almanac

InPhonic, PRA File Initial Public Offerings With SEC

Advertisement



David A. Steinberg, chairman and chief executive, owns 25 percent of Inphonic, which decided not to proceed with an IPO it registered in late 2002. (Susan Biddle -- The Washington Post)


_____Local Tech News_____
BioVeris Sues Executive's Son (The Washington Post, Jun 17, 2004)
BioVeris Investigating Joint Venture (The Washington Post, Jun 16, 2004)
High Court Allows FCC To Throw Out Phone Rules (The Washington Post, Jun 15, 2004)
More Headlines
Tech Events Calendar
_____Interactive Primer_____
Understanding Regulatory Policy
_____Related SEC Articles_____
Ex-SEC Chiefs Back Mutual Fund Plan (The Washington Post, Jun 16, 2004)
Wanted: Legal Superstars (The Washington Post, Jun 14, 2004)
4 Top the Wish Lists Of Other Law Firms (The Washington Post, Jun 14, 2004)
More SEC News
E-Mail This Article
Print This Article
Permission to Republish
By Yuki Noguchi and Raymund Flandez
Washington Post Staff Writers
Tuesday, June 15, 2004; Page E05

Two local companies, which had both shelved earlier attempts to sell shares to the public, said in filings yesterday with the Securities and Exchange Commission that they intended to raise money through initial public offerings.

InPhonic Inc., which sells wireless services and devices over the Internet, said it wanted to raise up to $100 million by offering shares to the public. This is the second time the Washington-based company has filed for an IPO. It registered in late 2002 but decided not to go forward.

PRA International, a McLean outsourcing company that manages clinical trials for companies trying to get Food and Drug Administration approval for their drugs, said it wanted to raise up to $143.8 million. In 1997, the company, then named Pharmaceutical Research Associates Inc., registered with the SEC but declined to go forward, said Patrick Donnelly, PRA's president and chief executive.

InPhonic has grown rapidly in recent years, although it has never generated a profit. Sales have gone from $13 million in 2001 to $119 million last year, according to its SEC filing. The company lost $37 million in 2003.

David A. Steinberg, chairman and chief executive, declined to comment. Steinberg owns 25 percent of the company, according to the SEC filing.

Deutsche Bank Securities Inc., J.P. Morgan Securities Inc., Thomas Weisel Partners LLC, Allen & Co. LLC, and Pacific Crest Securities Inc. will underwrite the offering.

PRA decided to go public now "to capitalize on the growth of the company and the current situation in the markets," Donnelly said. Credit Suisse First Boston; Bear, Stearns & Co.; William Blair & Co.; and Jefferies & Co. are underwriters. PRA earned $13.2 million on $290 million of revenue during 2003.

Donnelly said Genstar Capital LLP, a San Francisco investment firm, owns roughly 60 percent of PRA and the management employees own the rest. Genstar bought its share from the Carlyle Group, a Washington private equity firm, in 2001. Carlyle invested in PRA in 1996. PRA, which was founded in 1976, now has 2,500 employees in five continents. In 2003, it had revenue of about $290 million, according to its Web site.


TechNews.com Home

© 2004 The Washington Post Company

Company Postings: Quick Quotes | Tech Almanac
About TechNews.com | Advertising | Contact TechNews.com | Privacy
My Profile | Rights & Permissions | Subscribe to print edition | Syndication